Certain antibiotic-resistant infections could be treated with precision medicine in the future, thanks to a new resource mapping plasmids the ultimate vehicle of rapid bacterial evolution.

Coralville-based Integrated DNA Technologies, a global leader in genomics solutions, has joined forces with Elegen, a leader in next-generation DNA ...

PLC (AIM: 4BB) (“4basebio”), a company which develops and commercializes the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, today announced that it has received ...

The first-of-its-kind in-depth bacterial evolutionary map could pave the way for the development of precision treatments for certain ...

The first-of-its-kind in-depth bacterial evolutionary map could pave the way for the development of precision treatments for ...

Toxicity related to the systematic delivery of IL-12, a well-known and widely researched anti-tumor cytokine, has limited its ...

Integrated DNA Technologies and Elegen are uniting to revolutionize the long DNA synthesis market, marking the launch of ...

Scientists in The Wistar Institute lab of David B. Weiner, Ph.D., have described a next-generation vaccination technology ...

Creative Diagnostics, a global provider of reagents and analytical services, has released its innovative Gene Copy Number ...

Imunon has announced the alignment of the FDA with the Phase III OVATION 3 trial of IMNN-001 for ovarian cancer protocol.

The phase 3 trial design evaluating IMNN-001 in newly diagnosed advanced ovarian cancer has been finalized among regulatory ...

A new study in the journal Human Gene Therapy indicates that DNA impurities derived from plasmid and host cell DNA are ...